Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany

Datos Bibliográficos

ID15360489
AutoresMerle M Böhmer (0000-0002-2672-7481, Robert Koch Institute, autor de correspondencia), Dietmar Walter (Charité - Universitätsmedizin Berlin), Gerhard Falkenhorst (0000-0003-1458-4847, Robert Koch Institute), Stephan Müters (Robert Koch Institute), Gérard Krause (0000-0003-3328-8808, Robert Koch Institute), Ole Wichmann (0000-0003-2353-7188, Robert Koch Institute)
Año2012
Volumen12
Número1
Páginas938-938
Fecha de publicación2012-10-31
Open AccessSí
TipoARTICLE
RevistaBMC Public Health (JOURNAL)
Identificadores de la revistaISSN: 1471-2458 • E-ISSN: 1471-2458
EditorialBioMed Central (PUBLISHER • GB)
DOI10.1186/1471-2458-12-938
PMID23113995
PMCIDPMC3527143
OpenAlexW2171761905
IdiomaEN
Citas recibidas9
Referencias citadas24

Seasonal influenza vaccination coverage in Germany remains in all target groups below 75%, which is a declared goal of the European Union. Our results suggest that controversial public discussions about safety and the benefits of pandemic influenza vaccination may have contributed to both a very low uptake of pandemic vaccines and a decreased uptake of seasonal influenza vaccines in the first post-pandemic season. In the upcoming years, the uptake of seasonal influenza vaccines should be carefully monitored in all target groups to identify if this trend continues and to guide public health authorities in developing more effective vaccination and communication strategies for seasonal influenza vaccination

Biostatistics · Coronavirus disease 2019 (COVID-19 · Disease · Environmental health · Human mortality from H5N1 · Infectious disease (medical specialty · Pandemic · Population · Public health · Seasonal influenza · Vaccination · Demography · Influenza Virus Research Studies · Medicine · Respiratory viral infections research · Vaccine Coverage and Hesitancy · Internal Medicine · Virology

Herramientas

Abrir DOISci-HubOpen Access